Iqra Mumal, MSc,  —

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

Articles by Iqra Mumal

Mitochondrial Replacement Therapy Shows Promise at Preventing Disease, But Challenges Remain

Because treatment for mitochondrial DNA diseases is largely limited to addressing only symptoms, researchers are increasingly looking at mitochondrial replacement therapies as a way to allow women to have genetically related children while reducing the risk of transmitting disease. Mitochondrial replacement therapies involve a new and innovative technology to prevent…

Mitochondria-Targeting Generic Medicine Can Effectively Combat PAH, Study Shows

Treating pulmonary arterial hypertension (PAH) patients with the generic medicine dichloroacetate (DCA), which activates mitochondrial function, decreased pulmonary arterial pressure and improved the ability to walk, a new study shows. The study, “Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients,” was published in the…

Levels of FGF-21 Protein Could Help Doctors Diagnose Mitochondrial Disease, Study Reports

High levels of the FGF-21 protein may be a better indicator of mitochondrial disease than many currently used diagnostic tools, a study reports. This is particularly true in adults with chronic progressive external ophthalmoplegia, whose hallmark is weakness or paralysis of extraocular muscles, researchers said. The seven extraocular muscles consist of six that control eye…